Achieve Life Sciences, Inc. (ACHV) stock
ACHVNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31Also trades as QUIT
$6.72+0.34 (+5.33%)
Close on Nov 6, 2026Market cap $691.50MP/E –Yield –
Achieve Life Sciences pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Achieve Life Sciences's pe ratio was 25.0× on Jan 31, 2017, against 52.9× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2017 | Jan 31, 2017 | 25.0× | +2.7 |
| 2016 | Dec 30, 2016 | 22.3× | +17.0 |
| 2015 | Dec 31, 2015 | 5.2× | −47.6 |
| 2011 | Jul 29, 2011 | 52.9× | – |
See a number that looks wrong?